Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000897096 | SCV001041216 | benign | not provided | 2023-08-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000897096 | SCV002504028 | likely benign | not provided | 2020-03-09 | criteria provided, single submitter | clinical testing | See Variant Classification Assertion Criteria. |
Ambry Genetics | RCV002515059 | SCV003758278 | uncertain significance | Inborn genetic diseases | 2020-12-07 | criteria provided, single submitter | clinical testing | The c.3746G>A (p.R1249Q) alteration is located in exon 13 (coding exon 13) of the CRB2 gene. This alteration results from a G to A substitution at nucleotide position 3746, causing the arginine (R) at amino acid position 1249 to be replaced by a glutamine (Q). The in silico prediction for the p.R1249Q alteration is inconclusive. Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
OMIM | RCV000157658 | SCV000207609 | pathogenic | Focal segmental glomerulosclerosis 9 | 2015-01-08 | no assertion criteria provided | literature only | |
Reproductive Health Research and Development, |
RCV000157658 | SCV001142403 | uncertain significance | Focal segmental glomerulosclerosis 9 | 2020-01-06 | no assertion criteria provided | curation | NM_173689.5:c.3746G>A in the CRB2 gene has an allele frequency of 0.025 in Ashkenazi Jewish subpopulation in the gnomAD database. 4 homozygous occurrences are observed in the gnomAD database. Ebarasi et al. reported a homozygozity in a patient with Steroid-Resistant Nephrotic Syndrome in a consanguineous family (PMID: 25557779). We interpret it as variant of uncertain significance (VUS). ACMG/AMP criteria applied: BS1. |